BNTC
What one share of Benitec Biopharma holds
Pharmaceutical Preparations
Benitec Biopharma Inc. (“Benitec” or the “Company” or in the first person, “we” or “our”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California.
Benitec Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.98 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.36 |
| Cash and investments | $5.23 |
| Book value | $5.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | $0.22 | $0.03 | $0.37 | — | — |
| 2020 | $0.01 | −$0.58 | $0.01 | −$0.53 | — | — |
| 2021 | $0.00 | −$0.23 | $0.00 | −$0.22 | — | — |
| 2022 | $0.01 | −$2.71 | $0.00 | −$2.36 | — | — |
| 2023 | $0.00 | −$1.01 | $0.00 | −$0.93 | — | — |
| 2024 | $0.00 | −$1.22 | $0.01 | −$1.07 | — | $4.68 |
| 2025 | — | −$1.05 | $0.00 | −$0.65 | — | $3.71 |
| 2026 | — | −$0.98 | $0.00 | −$0.36 | — | $5.14 |